IRCT20150101020514N20
Not yet recruiting
Phase 2
Evaluating the safety and effectiveness of injectable gel with the ATP POUYA brand, for correcting nasolabial folds
Pouya Teb Tools Company0 sites30 target enrollmentTBD
ConditionsSkin aging.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Skin aging.
- Sponsor
- Pouya Teb Tools Company
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 \-65 years old men and women
- •Moderate to severe nasolabial folds based on Allergan criteria.
- •The opportunity to accompany the visit programs and study process.
- •Signing the informed consent form and agree to a 6\-month follow\-up.
Exclusion Criteria
- •Previous hyaluronic acid (HA)\-based dermal filler treatment(s) injected within the last 12 months prior to enrollment.
- •Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non\-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry
- •Planning to undergo any of these procedures at any time during the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Safety and effectiveness of injectable gel with the Perjunse brandSkin aging.IRCT20150101020514N24Pars Fardad Nano Technology Company30
Recruiting
Phase 2
Evaluating the safety and effectiveness of injectable gel with the W&O XtraIII brandIRCT20190210042676N30Ara Teb Gostar Soroush Company30
Recruiting
Phase 1
Investigating the effect of stromal/mesenchymal stem cell-derived exosomes in patients with perianal fistulaIRCT20240128060828N1Tehran University of Medical Sciences30
Recruiting
Phase 1
Safety and effectiveness assessment of injectable suspension of Inshape x Radiance plus for the treatment of the back of hand wrinklesIRCT20150101020514N31ano Darou Pajouhan Pardis Company15
Recruiting
Phase 2
Evaluation of an injectable solution with the brand name ®Embella in order to reduce submental fat.Submental fat.IRCT20190210042676N29Zist orchid pharmed Company20